Nasal cavity hemostasis set
By designing a multi-layered nasal hemostasis kit with saline dispensing, the problems of balloon rupture and mismatched hemostatic materials were solved, achieving safe and effective nasal hemostasis and reducing patient discomfort.
Patent Information
- Application Number
- CN202423030911.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-10
- Publication Date
- 2026-02-17
- Estimated Expiration
- 2034-12-10
AI Technical Summary
Existing nasal hemostasis kits pose a risk of saline solution flowing into the nasopharynx due to balloon rupture, and the hemostatic materials may not be compatible with the nasal cavity, resulting in poor hemostasis or patient discomfort.
A nasal hemostasis kit was designed, which includes a balloon and a hemostasis mechanism. The balloon consists of a first balloon, a second balloon and an auxiliary cavity. The hemostasis mechanism consists of multiple third balloons, a bandage and a ventilation tube. Through the multi-layer balloon design and saline distribution, the risk of rupture is reduced and the fit is improved.
It effectively blocks the nasopharyngeal passage, reduces saline leakage, improves hemostasis, alleviates patient discomfort, and reduces pressure on the nasal cavity wall.
Smart Images
Figure CN223914166U_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The utility model belongs to the technical field of medical equipment, especially relates to nasal cavity hemostasis set. BACKGROUND
[0002] In the medical field, nasal cavity bleeding is a common clinical problem, which can be caused by trauma, nasal diseases, systemic diseases and other reasons. If nasal cavity bleeding is not treated in time and effectively, blood may flow into the oral cavity and trachea, causing discomfort to the patient and even endangering life. Therefore, nasal cavity hemostasis set plays an important role in medical practice.
[0003] However, the existing nasal cavity hemostasis set has some limitations in design and application. First, the traditional nasal cavity hemostasis set usually adopts a single balloon design, which expands by injecting physiological saline into the balloon to block the nasopharyngeal passage of the patient. However, this design has potential risks. Once the balloon is damaged, a large amount of physiological saline will flow into the nasopharyngeal passage, causing unnecessary harm to the patient's body.
[0004] Secondly, the existing nasal cavity hemostasis set also has deficiencies in the application of hemostatic materials. The traditional method is to fix the hemostatic material directly to the pipe body and then insert it into the patient's nasal cavity. However, due to the difference in the size of the patient's nasal cavity, if the hemostatic material is small, this fixing method can easily cause the hemostatic material to not fit well with the inner wall of the patient's nasal cavity, affecting the hemostatic effect. If the hemostatic material is large, this fixing method can easily cause discomfort to the patient.
[0005] Therefore, it is necessary to invent a nasal cavity hemostasis set. CONTENT OF THE UTILITY MODEL
[0006] The utility model aims at providing a nasal cavity hemostasis set to solve the problems mentioned in the background.
[0007] To solve the above technical problems, the utility model is realized by the following technical scheme:
[0008] The utility model is a nasal cavity hemostasis set, which comprises an outer pipe, a balloon, a hemostatic mechanism, a joint, an inner pipe, a first valve body and a liquid injection pipe. One end of the outer pipe is fixed with the balloon, and the other end of the outer pipe is fixed with the joint. The inner pipe is fixed inside the outer pipe, the balloon and the joint. The other end of the joint is fixed with the first valve body, and the other end of the first valve body is fixed with the liquid injection pipe. The joint and the balloon are provided with the hemostatic mechanism, and the hemostatic mechanism is fixed on the outer side of the outer pipe.
[0009] Further, the balloon comprises a first balloon body, a second balloon body, an expansion cavity and an auxiliary cavity, one end of the first balloon body is fixed with the outer tube, and the other end of the first balloon body is fixed with the inner tube; the inside of the first balloon body is provided with the expansion cavity, wherein the expansion cavity is communicated with the outer tube; the outside of the first balloon body is fixed with the second balloon body, wherein the auxiliary cavity is arranged between the first balloon body and the second balloon body, and the inside of the auxiliary cavity is filled with a small amount of normal saline; after the balloon is inserted into the nasopharyngeal channel, the bleeding in the nasal cavity cannot flow into the oral cavity and the trachea, and the danger in use is reduced.
[0010] Further, the hemostatic mechanism comprises a third balloon body, a bandage, a ventilation pipe, a fixing frame and a second valve body, the third balloon body is provided with a plurality of third balloon bodies, adjacent third balloon bodies are arranged in close contact, and the third balloon bodies are fixed on the outside of the outer tube; the outside of the third balloon body is wrapped with the bandage, and the outside of the third balloon body is fixed with the ventilation pipe; the ventilation pipe is fixed and penetrates through the fixing frame, and the end of the ventilation pipe close to the fixing frame is fixed with the second valve body; the bleeding port of the inner wall of the nasal cavity can be hemostatic, and the pressure on the inner wall of the nasal cavity is small.
[0011] Compared with the prior art, the utility model has the advantages of the following beneficial effects:
[0012] 1. The balloon is arranged, after the balloon is inserted into the nasopharyngeal channel, the normal saline is injected into the expansion cavity of the balloon through the outer tube, the second balloon body tightly seals the nasopharyngeal channel, effectively prevents the bleeding in the nasal cavity from flowing into the oral cavity and the trachea, provides timely hemostasis and protection for the patient, when the second balloon body is accidentally damaged, a small amount of normal saline in the auxiliary cavity flows into the nasopharyngeal channel, but the damage to the patient's body is small due to the small amount, in addition, if the first balloon body is damaged, the normal saline in the expansion cavity flows into the auxiliary cavity, and unnecessary damage to the patient caused by a large amount of normal saline leakage is avoided.
[0013] 2. The hemostatic mechanism is arranged, the hemostatic medicine is applied to the bandage, and the third balloon body is inflated through the ventilation pipe, so that the bandage is closely attached to the inner wall of the nasal cavity of the patient, and the hemostatic medicine can accurately act on the bleeding port, and the hemostatic effect is improved; secondly, compared with the single compression mode, the pressure on the inner wall of the nasal cavity is small due to the multiple third balloon body design of the hemostatic mechanism, and the discomfort of the patient is reduced. ACCURACY OF DRAWINGS
[0014] In order to more clearly illustrate the technical scheme of the embodiments of the present application, the following will briefly introduce the drawings needed to be used in the embodiment description, obviously, the drawings in the following description are only some embodiments of the present application, and for those skilled in the art, other drawings can also be obtained according to these drawings without creative labor.
[0015] Fig. 1 It is a structural schematic diagram of the present application.
[0016] Fig. 2 It is a structural schematic diagram of the balloon of the present application.
[0017] Fig. 3 It is a structural schematic diagram of the hemostasis mechanism of the present application.
[0018] In the drawings:
[0019] 1-outer tube, 2-balloon, 21-first capsule, 22-second capsule, 23-expansion cavity, 24-assistant cavity, 3-hemostasis mechanism, 31-third capsule, 32-bandage, 33-ventilation tube, 34-fixing frame, 35-second valve body, 4-joint, 5-inner tube, 6-first valve body, 7-liquid injection tube. DETAILED DESCRIPTION
[0020] The technical scheme in the embodiments of the present application will be described clearly and completely in combination with the drawings in the embodiments of the present application, obviously, the described embodiments are only some embodiments of the present application, but not all the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without creative labor are within the protection scope of the present application.
[0021] In the description of the present application, it is understood that the terms "upper", "middle", "outer", "inner", "periphery" and the like indicate the orientation or positional relationship, which are only for the convenience of describing the present application and simplifying the description, and do not indicate or imply that the indicated components or elements must have a particular orientation, be constructed and operated in a particular orientation, therefore, it cannot be understood as a limitation of the present application.
[0022] Please refer to Fig. 1 As shown in the drawings, the present application is a nasal cavity hemostasis set, which comprises an outer tube 1, a balloon 2, a hemostasis mechanism 3, a joint 4, an inner tube 5, a first valve body 6 and a liquid injection tube 7, one end of the outer tube 1 is fixed with the balloon 2, and the other end of the outer tube 1 is fixed with the joint 4, wherein the inner tube 5 is fixed inside the outer tube 1, the balloon 2 and the joint 4; the other end of the joint 4 is fixed with the first valve body 6, wherein the other end of the first valve body 6 is fixed with the liquid injection tube 7; the hemostasis mechanism 3 is arranged between the joint 4 and the balloon 2, wherein the hemostasis mechanism 3 is fixed on the outer side surface of the outer tube 1.
[0023] As Fig. 2 shown, the balloon 2 includes a first balloon body 21, a second balloon body 22, an expansion cavity 23 and an auxiliary cavity 24, one end of the first balloon body 21 is fixed with the outer tube 1, and the other end of the first balloon body 21 is fixed with the inner tube 5; the inside of the first balloon body 21 is provided with the expansion cavity 23, wherein the expansion cavity 23 is communicated with the outer tube 1; the outer side of the first balloon body 21 is fixed with the second balloon body 24, wherein the first balloon body 21 and the second balloon body 22 are provided with the auxiliary cavity 24, the inside of the auxiliary cavity 24 is filled with a small amount of normal saline, after the balloon 2 is inserted into the nasopharyngeal passage, the normal saline can be injected into the expansion cavity 23 through the outer tube 1, so that the second balloon body 22 tightly seals the nasopharyngeal passage, so that the bleeding in the nasal cavity does not flow into the oral cavity and trachea, and at the same time, when the second balloon body 22 is damaged, a small amount of normal saline in the auxiliary cavity 24 flows into the nasopharyngeal passage, the small amount of normal saline causes less harm to the patient's body, and when the first balloon body 21 is damaged, the normal saline in the expansion cavity 23 flows into the auxiliary cavity 24, so that the patient's body is not harmed.
[0024] As Fig. 3 shown, the hemostatic mechanism 3 includes a third balloon body 31, a bandage 32, a ventilation pipe 33, a fixing frame 34 and a second valve body 35, the third balloon body 31 is provided with a plurality of, wherein adjacent third balloon bodies 31 are arranged in close contact, and the third balloon bodies 31 are fixed on the outer side of the outer tube 1; the outer side of the third balloon body 31 is wrapped with the bandage 32, and the outer side of the third balloon body 31 is fixed with the ventilation pipe 33; the ventilation pipe 33 is fixed and penetrates through the fixing frame 34, wherein the end of the ventilation pipe 33 close to the fixing frame 34 is fixed with the second valve body 35, in use, the hemostatic medicine can be applied to the bandage 32, then the hemostatic mechanism 3 is inserted into the nasal cavity, and then the corresponding third balloon body 31 is inflated through the ventilation pipe 33, so that the bandage 32 is arranged in close contact with the patient's nose, at this time, the hemostatic medicine on the bandage 32 can stop bleeding at the bleeding port of the nasal cavity wall, and at the same time, since a plurality of third balloon bodies 31 are arranged, the pressure on the nasal cavity wall is small.
[0025] Please refer to Figs. 1-3 shown, the utility model discloses a nasal cavity hemostasis set, and its working principle is as follows: in use, first, the balloon 2 is inserted into the nasopharyngeal passage, then the normal saline is injected into the balloon 2 through the liquid injection pipe 7, so that the balloon 2 tightly seals the nasopharyngeal passage, and at the same time, the hemostatic mechanism 3 is inserted into the nasal cavity, and the bleeding port of the nasal cavity is hemostatic through the hemostatic mechanism 3, at this time, the patient can breathe through the inner tube 5, and after use, the first valve body 6 and the second valve body 35 can be opened respectively, so that the expansion cavity 23 and the third balloon body 31 can be depressurized, thereby facilitating the removal from the patient's body.
[0026] In the description of the present specification, the description referring to the terms "one embodiment", "an example", "a specific example" and the like means that the specific features, structures, materials or characteristics described in connection with the embodiment or example are included in at least one embodiment or example of the present application. In the present specification, the illustrative description of the above terms does not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.
[0027] The preferred embodiments of the present application disclosed above are only used to help explain the present application. The preferred embodiments do not describe all the details and limit the present application to the specific embodiments described. Obviously, according to the content of the present specification, many modifications and changes can be made. The present specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present application, so that the persons skilled in the art can well understand and utilize the present application. The present application is limited by the claims and the entire scope and equivalents thereof.
Claims
1. A nasal hemostasis kit, comprising an outer tube (1), a balloon (2), a hemostasis mechanism (3), a connector (4), an inner tube (5), a first valve body (6), and an injection tube (7), characterized in that: One end of the outer tube (1) is fixed with a balloon (2), and the other end of the outer tube (1) is fixed with a connector (4). An inner tube (5) is fixed inside the outer tube (1), the balloon (2) and the connector (4). The other end of the connector (4) is fixed with a first valve body (6), and the other end of the first valve body (6) is fixed with an injection tube (7). A hemostasis mechanism (3) is provided between the connector (4) and the balloon (2), and the hemostasis mechanism (3) is fixed on the outer side of the outer tube (1).
2. The nasal hemostasis kit as described in claim 1, characterized in that: The balloon (2) includes a first balloon body (21), a second balloon body (22), an expansion cavity (23), and an auxiliary cavity (24). One end of the first balloon body (21) is fixed to the outer tube (1), and the other end of the first balloon body (21) is fixed to the inner tube (5). An expansion cavity (23) is provided inside the first balloon body (21), wherein the expansion cavity (23) communicates with the outer tube (1). A second balloon body (22) is fixed to the outer side of the first balloon body (21), wherein an auxiliary cavity (24) is provided between the first balloon body (21) and the second balloon body (22), and the auxiliary cavity (24) is filled with a small amount of physiological saline.
3. The nasal hemostasis kit as described in claim 1, characterized in that: The hemostasis mechanism (3) includes a third bladder (31), a bandage (32), a ventilation tube (33), a fixation frame (34), and a second valve body (35). Several third bladders (31) are provided, with adjacent third bladders (31) fitting together, and each third bladder (31) is fixed to the outer side of the outer tube (1). The outer side of the third bladder (31) is wrapped with a bandage (32), and each outer side of the third bladder (31) is fixed with a ventilation tube (33). Each ventilation tube (33) is fixed and passes through the fixation frame (34), and the end of each ventilation tube (33) near the fixation frame (34) is fixed with a second valve body (35).